Antibiotics combination therapy in patients with active ulcerative colitis: a double-blind placebo-controlled multicenter trial

被引：0

作者：

Ohkusa, Toshifumi ^{[1
]}

Kato, Kimitoshi ^{[2
]}

Terao, Shuichi ^{[2
]}

Chiba, Toshimi ^{[2
]}

Mabe, Katsuhiro ^{[2
]}

Murakami, Kazunari ^{[2
]}

Mizokami, Yuji ^{[2
]}

Takeuchi, Yoshiaki ^{[2
]}

Sugiyama, Toshiro ^{[2
]}

Kudo, Takahiko ^{[2
]}

Yanaka, Akinori ^{[2
]}

Yamato, Shigeru ^{[2
]}

Yokoyama, Tetsuji ^{[2
]}

Okayasu, Isao ^{[2
]}

Sato, Nobuhiro ^{[1
]}

Watanabe, Sumio ^{[1
]}

机构：

[1] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan

[2] Japan UC Antibiot Therapy Study Grp, Tokyo, Japan

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2007年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：A179 / A179

页数：1

共 50 条

[21] Impact of curcuma longa on clinical activity and inflammatory markers in patients with active ulcerative colitis: a double-blind randomised placebo-controlled trial
Kumar, S.
Dutta, U.
Shah, J.
Singh, P.
Vaishnavi, C.
Prasad, K. K.
Singh, K.
JOURNAL OF CROHNS & COLITIS, 2019, 13 : S322 - S323
[22] Efficacy of Vedolizumab in Ulcerative Colitis by Prior Treatment Failure in GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
Feagan, Brian
Sands, Bruce
Sankoh, Serap
Milch, Catherine
Fox, Irving
INFLAMMATORY BOWEL DISEASES, 2012, 18 : S25 - S26
[23] Efficacy of Vedolizumab in Ulcerative Colitis by Prior Treatment Failure in GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
Feagan, Brian
Sands, Bruce
Sankoh, Serap
Milch, Catherine
Fox, Irving
INFLAMMATORY BOWEL DISEASES, 2012, 18 : S1 - S2
[24] Efficacy of Vedolizumab in Ulcerative Colitis by Prior Treatment Failure in GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
Parikh, Asit
INFLAMMATORY BOWEL DISEASES, 2012, 18 : S26 - S26
[25] ORAL 5-AMINOSALICYLIC ACID THERAPY FOR MILD TO MODERATELY ACTIVE CHRONIC ULCERATIVE-COLITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
SCHROEDER, KW
TREMAINE, WJ
DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (10) : S320 - S320
[26] DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF OLSALAZINE IN THE TREATMENT OF ULCERATIVE-COLITIS
ZINBERG, J
MOLINAS, S
DAS, KM
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1990, 85 (05): : 562 - 566
[27] Safety of celecoxib in patients with ulcerative colitis in remission: A randomized, double-blind, placebo-controlled study
Sandborn, WJ
Stenson, WF
Brynskov, J
Steidle, G
Robbins, J
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S257 - S258
[28] Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction study
Danese, S.
Neurath, M.
Kopon, A.
Zakko, S.
Simmons, T.
Fogel, R.
Maccarone, J.
Zhan, X.
Usiskin, K.
Chitkara, D.
JOURNAL OF CROHNS & COLITIS, 2018, 12 : S4 - S5
[29] Budesomide in lymphocytic colitis - A randomized, double-blind, placebo-controlled trial
Miehlke, Stephan
Madisch, Ahmed
Bethke, Birgit
Wonschik, Susann
Kuhlisch, Eberhard
Beckmann, Renate
Morgner, Andrea
Mueller, Ralph
Greinwald, Roland
Baretton, Gustavo
Seitz, Gerhard
Stolte, Manfred
GASTROENTEROLOGY, 2007, 132 (04) : A131 - A132
[30] DOXAZOSIN IN COMBINATION WITH ATENOLOL IN ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER TRIAL
SEARLE, M
DATHAN, R
DEAN, S
CHRISTENSEN, CC
WESTHEIM, A
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (03) : 299 - 300

← 1 2 3 4 5 →